Neuroone Medical Technologies is trading 6.56% higher at $0.86 in pre-market, based on the supplied quote; no clear catalyst for October 27 was identified.
- The stock closed at $0.80 on October 26.
- The latest identified company news was an October 22 purchase order for its StereoCED platform supporting a pharmaceutical company’s preclinical research program; it predates the move, and its role as a cause is unconfirmed.
- Broader market indices were modestly higher, but not by more than 0.5%, providing no stronger market explanation.